Patent ID: 7138147
Filing Date: 2006-11-21
Classification: A61K,A61P

Abstract:
1. A pharmaceutical composition useful for treating a hematological cancer in a mammal, consisting of (A) at least one arsenic sulfide compound, (B) a pharmaceutically acceptable carrier or excipient, and optionally (C) an effective amount of a therapeutic agent selected from the group consisting of mustard compounds, nitrogen mustard, chliorambucil, melphalan, cyclophosphamide busulfan, 6-mercaptopurine, 6-thioguanine, cytarabine, cytosine arabinoside, 5-fluorouracil, floxuridine, methotrexate, vincristine, vinblastine, taxol, etoposide, temiposide, dactinomycin, daunorubicin, doxorubicin, epirubicin, mitoxantron, bleomycin, mitomycin, cisplatin carboplatin, estramustine phosphate, hydroxyurea, BCNU, procarbazine, VM-26 (vumon), interferons and all-trans retinoic acid.